Osteoporosis is typically treated with orally administered drugs, which may take up to a year to have a noticeable effect. A ...
News Medical on MSN6d
Combined therapy could revolutionize the prevention of osteoporosis fracturesOsteoporosis is a disease in which bone resorbs faster than it is formed, gradually weakening its structure over time and ...
OS Therapies (NYSE:OSTX) is up ~65% in premarket trading Wednesday after releasing phase 2b data on OST-HER2 for prevention of recurrent, fully resected, lung metastatic osteosarcoma. Results ...
OS Therapies Incorporated (NYSE: OSTX) announced it had entered into an Asset Purchase Agreement with Ayala Pharmaceuticals, Inc. Under this agreement, OS Therapies will acquire all HER2 and Listeria ...
https://www.tipranks.com/news/the-fly/immunoprecise-antibodies-develops-new-class-of-glp-1-therapies-through-ai Maxim analyst Jason McCarthy raised the firm’s price ...
OS Therapies previously disclosed that it completed a $7.1M financing, priced at $4.00 per share primarily with existing shareholders, that provides the company with sufficient cash runway into ...
OS Therapies (OSTX) announced it has entered into an asset purchase agreement to acquire the listeria monocytogenes-based immuno-oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback